Navigation Links
French Regulator Lina Ertle, FDA's Jeffrey Baker and Patrick Swann Confirmed Speakers at 2013 PDA/FDA Process Validation Workshop
Date:3/7/2013

BETHESDA, Md., March 7, 2013 /PRNewswire-USNewswire/ -- The Parenteral Drug Association (PDA) announced today that three high-level regulators from the United States and Europe will speak at the 2013 PDA/FDA Process Validation Workshop, May 20 – 21 at the Hyatt Regency in Bethesda. They are: 

  • Jeffrey Baker , Deputy Director, Office of Biotechnology, CDER, FDA
  • Lina Ertle , Quality Assessor, ANSM (France)
  • Patrick Swann , Deputy Director, Division of Monoclonal Antibodies, CDER, FDA

(Logo: http://photos.prnewswire.com/prnh/20130226/DC66667LOGO)

"With global regulatory expectations for process control and validation changing in recent years, PDA's members recognize the importance of engaging health authority representatives at a workshop like this," said Richard Johnson , PDA President and CEO. "PDA has a long history of providing forums for manufacturers to exchange the latest thinking with their regulatory counterparts, and it is common for representatives of health authorities from different countries to appear at our meetings to open dialogue with industry experts."

The workshop is intended to help industry learn about the U.S. and European regulatory perspectives on process validation. In recent years, regulators have expected manufacturers to take a life-cycle approach to process validation and utilize risk-management and statistical tools. Process validation experts from industry, representing companies like Pfizer, Baxter Healthcare, and Amgen, also will present.

More information on the workshop is available at http://www.pda.org/processval2013.

About PDA:

The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its more than 9,500 members worldwide.

Media Inquiries: Walt Morris , 301-656-5900; morris@pda.org


'/>"/>
SOURCE Parenteral Drug Association
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. French Lifestyle Secret Finally Revealed: Lycotec Publishes Unexpected Findings on Roquefort Cheese
2. French Government Agrees to Fund Study of the PneumRx RePneu Lung Volume Reduction Coil
3. Pycnogenol® (French Maritime Pine Bark Extract) Shown To Improve Endothelial Function And Reduce Oxidative Stress In New Clinical Trial
4. PCMA Recruits Wendy Krasner as New Vice President of Regulatory Affairs
5. CPhI Announces its 2nd Annual Global Pharma Regulatory Summit
6. Emerging Pharmaceutical Market in South Africa - Proposed Introduction of New Drug Regulatory Agency (SAHPRA) to Accelerate Drug Registration Process
7. Marken Expands Regulatory And Technical Excellence In Logistics
8. Proposed Regulatory Uniformity to Boost Venture Capital Investments in Healthcare Arena, Says Frost & Sullivan
9. Hadasit Bio-Holdings Portfolio Companies Receive Funding to Support Clinical Trial Preparations and Obtain Regulatory Approvals in U.S. and Europe
10. Global Healthcare, Regulatory and Reimbursement Landscape Forecasts and Trends in UAE, Canada and Taiwan
11. Memorandum of Agreement: Training State Regulators to Advance the Quality of Orthopaedic Care for China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... April 24, 2017 Solentim, the developer ... the addition of a major new product line ... Seeding,). The VIPS has been developed for automatically ... microplates as part of the process to generate ... simple and more reliable solution when compared to ...
(Date:4/20/2017)... Texas , April 20, 2017  Vivify Health, ... mobile devices, has been awarded a very significant patent ... via EMRs to continual care via digital health.  This ... key intellectual property and further secures Vivify,s position as ... launched in 2009, was the first company to apply ...
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... 2017 , ... ProRehab Physical Therapy (PRPT) is ... therapy provider for Derby City CrossFit, effective immediately. , In addition to treating ... effectively as possible, ProRehab’s sports physical therapists will work with athletes to maximize ...
(Date:4/25/2017)... ... 2017 , ... A recent report from the Wisconsin Institute ... 2015-16 school year across Wisconsin’s public schools, charter schools, and private schools participating ... student test score performance, the report’s limited analyses fail to provide answers as ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... they rely on contracted partners to help with process innovation in drug formulation ... drug formulation experience along with state-of-the-art analytical equipment in support of their development ...
(Date:4/25/2017)... ... 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest quality of ... I focus on preventative care with all my patients to alleviate possible future issues. I ... free to contact my office and my trained staff will assist you in any way ...
(Date:4/25/2017)... ... 25, 2017 , ... Vetoquinol USA® , a world-class ... part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in ... immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair of ...
Breaking Medicine News(10 mins):